Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder

ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis

Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt261 · Cited by 1,822

Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., et al. (2019) · Pediatrics · doi:10.1542/peds.2019-2528 · Cited by 1,562

Attention-deficit/hyperactivity disorder

Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis

Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30269-4 · Cited by 1,402

Meta-analysis of Functional Magnetic Resonance Imaging Studies of Inhibition and Attention in Attention-deficit/Hyperactivity Disorder: Exploring Task-Specific, Stimulant Medication, and Age Effects

Hart, H., Radua, J., Nakao, T., Mataix-Cols, D., & Rubia, K. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.277 · Cited by 764

Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples

Hoogman, M., Muetzel, R., Guimaraes, J. P., Shumskaya, E., Mennes, M., Zwiers, M. P., Jahanshad, N., Sudre, G., Wolfers, T., Earl, E. A., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18091033 · Cited by 467

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

Leucht, S., Hierl, S., Kissling, W., Dold, M., & Davis, J. M. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.096594 · Cited by 451

Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336

Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis

Rubia, K., Alegria, A. A., Cubillo, A. I., Smith, A. B., Brammer, M. J., & Radua, J. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.016 · Cited by 315

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.

Raman, S. R., Man, K. K. C., Bahmanyar, S., Bérard, A., Bilder, S., Boukhris, T., Bushnell, G., Crystal, S., Furu, K., KaoYang, Y.-H., et al. (2018) · Lancet psychiatry · doi:10.1016/s2215-0366(18)30293-1 · Cited by 285

The effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention-deficit/hyperactivity disorder

Torun, M., Pınar, Z. V., & İlhan, Ş. (2025) · BMC Ophthalmology · doi:10.1186/s12886-025-03886-3 · Cited by 3

Comparative cardiovascular side effects of medications for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis

Lannes, A., Farhat, L. C., Giovane, C. D., Cipriani, A., Revet, A., & Cortese, S. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062748 · Cited by 3

Attention Deficit/Hyperactivity Disorder

Soutullo, C. A. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009334730.031 · Cited by 3

Decision aid development and its acceptability among adults with attention‐deficit/hyperactivity disorders regarding treatment discontinuation after remission

Tsujii, N., Okada, T., Usami, M., Kuwabara, H., Fujita, J., Negoro, H., Iida, J., Aoki, Y., Takaesu, Y., & Saito, T. (2022) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.57 · Cited by 2

Comorbid ADHD and schizophrenia and the use of psychostimulants: a scoping review protocol

Bamford, J., Qurashi, I., Axiaq, A., Marwaha, S., & Husain, N. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-090290 · Cited by 2

Use of Antidepressants Decreased After Initiation of ADHD Treatment in Adults—A Finnish Nationwide Register Study Describing Use of ADHD and Non‐ ADHD Medication in People With and Without ADHD

Westman, E., Prami, T., Kallio, A., Iso‐Mustajärvi, I., Jukka, J., Raittinen, P. V. H., Korhonen, M. J., Puustjärvi, A., & Leppämäki, S. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.70007 · Cited by 2

Rodent research of attention-deficit/hyperactivity disorder: insights into widely used animal models

Corona, J. C. (2025) · Laboratory Animal Research · doi:10.1186/s42826-025-00255-5 · Cited by 3

Methylphenidate stabilizes dynamic brain network organization during tasks probing attention and reward processing in stimulant-naïve children with ADHD

Nugiel, T., Fogleman, N. D., Lyons, M. G., Sheridan, M. A., & Cohen, J. R. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03694-9 · Cited by 2

Connecting the dots and finding the way forward: Pharmacological, neuromodulatory, and psychotherapeutic interventions for the complex treatment of adult ADHD

Gonda, X., Döme, P., Balogh, L., Baradits, M., & Réthelyi, J. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.108997 · Cited by 3

Child training in the Child ViReal Support Program: Combining iVR-based cognitive training and CBT techniques in a pilot study

Pachiti, I., Milienos, F. S., Papadopoulos, T. C., & Dimitropoulou, P. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343364 · Cited by 2

Advances in the management of ADHD in children and adolescents

Robaey, P., Rogers, M., & Schachar, R. J. (2026) · BMJ · doi:10.1136/bmj-2024-082507 · Cited by 2

Probiotic Supplementation in Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of ADHD-Related and Emotional–Behavioral Outcomes

Yan, Y.-Z., Wu, H., Han, M., Zhao, L., & Mao, S. (2026) · Nutrients · doi:10.3390/nu18142357 · Cited by 2

Características das prescrições de metilfenidato em ambulatório de neuropediatria

de Lima, C. H., Paiola, G. C., Maier, A. M. R. R., Garcia, L. F., & Massuda, E. M. (2022) · Saúde em Debate · doi:10.1590/0103-11042022e515 · Cited by 3

Atomoxetine-Associated Maculopapular Rash

İNCE, N., & Sarı, S. A. (2023) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001776 · Cited by 2

Electronic Health Records for Research on Attention-Deficit/Hyperactivity Disorder Pharmacotherapy: A Comprehensive Review

Roy, S., Arturi, L., Parlatini, V., & Cortese, S. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0066 · Cited by 2

Cumulative ADHD medication use and risk of type 2 diabetes in adults: a Swedish Register study

Dong, Z., Zhang, L., Li, L., Liu, S., Brikell, I., Kuja‐Halkola, R., D'Onofrio, B. M., Butwicka, A., Guðbjörnsdóttir, S., Larsson, H., et al. (2024) · BMJ Mental Health · doi:10.1136/bmjment-2024-301195 · Cited by 2

Precision pharmacotherapy of atomoxetine in children with ADHD: how to ensure the right dose for the right person?

Guo, H., Huang, J., Wang, J., Fan, L., Li, Y., Wu, D., Liu, Q., & Chen, F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1484512 · Cited by 2

Medical management of ADHD in adults: part 1

Leaver, L. (2025) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2024.000019 · Cited by 2

Personalization of Pharmacological Treatments for ADHD: Why it is Advisable and Possible Options to Achieve it

Herrera-Morales, W. V., Ramı́rez-Lugo, L., Cauich-Kumul, R., Murillo‐Rodríguez, E., & Núñez-Jaramillo, L. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220509155413 · Cited by 3

Towards pathophysiology-based interventions for children with ADHD and increased screen time utilisation

Cortese, S. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104075 · Cited by 2

Caring for adolescents and young adults with attention-deficit/hyperactivity disorder in primary care: seizing opportunities to address youth mental health needs

Driscoll, H., Kimberg, A., & Chung, R. J. (2022) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001127 · Cited by 2

Therapeutic Use of Dopamine Enhancers (Stimulants)

Zuddas, A., & Carucci, S. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_138-1 · Cited by 1

Clinico-Demographic Profile of Children and Adolescents with Attention Deficit Hyperactivity Disorder Presenting to a Tertiary Care Centre: A Descriptive Cross-sectional Study

Karki, U., Sherchan, S., Sharma, A. P., & Jha, A. (2024) · Journal of Nepal Medical Association · doi:10.31729/jnma.8539 · Cited by 1

Differential Roles of Key Brain Regions: Ventral Tegmental Area, Locus Coeruleus, Dorsal Raphe, Nucleus Accumbens, Caudate Nucleus, and Prefrontal Cortex in Regulating Response to Methylphenidate: Insights from Neuronal and Behavioral Studies in Freely Behaving Rats

Dafny, N., Claussen, C. M., Frazier, E., & Liu, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115938 · Cited by 1

Medical management of ADHD in adults: part 2

Leaver, L. (2025) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2025.000019 · Cited by 1

Increased use of attention‐deficit/hyperactivity disorder drugs among children and adolescents with suicidal ideation: A real‐world registry study in Japan

Tsujii, N., Kihara, H., Hiraiwa, A., Tachibana, H., Ueno, M., Takasaki, A., Igarashi, C., Kaneko, N., Itagaki, K., Yamamoto, K., et al. (2025) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70170 · Cited by 1

Cannabis Use in a Community-Based Sample of Adults Diagnosed With ADHD: Prevalence, Impact on Symptoms, and Stimulant Side Effects

Ryan, J. E., Herens, A., Fruchtman, M., Veliz, P. T., Kelly, E. L., & Worster, B. K. (2025) · Journal of Attention Disorders · doi:10.1177/10870547251364575 · Cited by 1

Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review

Jung, D. (2026) · Annals of Child Neurology · doi:10.26815/acn.2025.01074 · Cited by 1

Pediatric patients with attention deficit and hyperactivity disorder and accidental injuries: a cohort study

Ferrão, T., Bravo, M., Ministro, D., Zenha, R., & Rebimbas, S. (2026) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20260394 · Cited by 1

Common and rare variant contributions to discontinuation of stimulant treatment in ADHD

Thirstrup, J. P., Duan, J., Marta Ribasés, A., Artigas, M. S., Albiñana, C., Dalsgaard, S., Faraone, S. V., Werge, T. M., Bybjerg‐Grauholm, J., Børglum, A. D., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03925-7 · Cited by 2

Dose-response, net clinical benefit and optimal dose ranges of stimulants in children and adolescents with ADHD: a network meta-analysis

Chang, Y., Ju, P., Hsieh, M., Liu, Y.-C., & Chang, C.-C. (2026) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-026-03025-3 · Cited by 1

Reinventing amlodipine

Grzymala, B., Halldórsdóttir, D. Þ., Thorsteinsson, H. S., þorfinnsdóttir, K., Sveinsdóttir, H. S., Parker, M. O., Foulquier, S., & Karlsson, K. Æ. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.104900 · Cited by 1

Atomoxetine Versus Placebo for Cognitive Deficits in Stimulant Use Disorder: A Systematic Review

Barroso, D., Kotochinsky, M., Alessi, M. R., Amador, W. F. O., Godoi, D. C., Sabloak, R., Pereira, S. I. D. S., Ansari, Y., Amorim, K. G., Barbosa, G., et al. (2026) · Substance use & addiction journal · doi:10.1177/29767342261443842

Comparative Risks of Pregnancy Complications in Women Prescribed Psychostimulants or Atomoxetine During Pregnancy Following Pre‐Pregnancy Stimulant Use

Tuan, W., Sarkar, N., Griffin, P. M., & Babinski, D. E. (2026) · Psychiatric Research and Clinical Practice · doi:10.1176/appi.prcp.20250149 · Cited by 1

Can parents believe websites’ information about methylphenidate’s side effects?

England, T. A., & Tuthill, D. P. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-320007 · Cited by 1

Digital Health: A New Frontier

Barracca, A., Ledda, S., Mancosu, G., Pintore, G., Quintaliani, G., Ronco, C., & KASHANI, K. B. (2023) · Journal of Translational Critical Care Medicine · doi:10.4103/jtccm-d-22-00018 · Cited by 11

Stimulant Drugs: Are They Specific for Attention Deficit Disorder or Are They Abused and Overused?

Belmaker, R. H., & Lichtenberg, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-40371-2_11 · Cited by 1

Ferramentas de ensino para auxílio da aprendizagem de crianças com TDAH: uma revisão da literatura

Guidi, J. G., Guidi, B., Britto, C. D. C., de Barros, R. T., Silva, E. M., & Morais, U. A. B. (2024) · Debates em Psiquiatria · doi:10.25118/2763-9037.2024.v14.1113 · Cited by 1

ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines

Cortese, S., Coghill, D., Fegert, J. M., Mattingly, G. W., Rohde, L. A., Wong, I. C. K., & Faraone, S. V. (2024) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-024-02443-5 · Cited by 1

The clinical pathway in ADMiRE, Ireland’s first public specialist service for children and adolescents with attention deficit hyperactivity disorder

McGrath, J. (2024) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2024.13 · Cited by 1

O uso da Atomoxetina e Metilfenidato na terapêutica do TDAH

de Sousa, C. A., Cavalcante, L. S., & Lima, C. P. V. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n3-145 · Cited by 1

Case Study on ADHD with Supportive Literature

(2024) · doi:10.56831/pssrp-04-113 · Cited by 1

Cinq stratégies populationnelles ayant contribué à la réduction des taux de suicide chez les adolescents et les jeunes adultes québécois

LESAGE, A. D., & Brousseau‐Paradis, C. (2024) · Santé mentale au Québec · doi:10.7202/1114406ar · Cited by 1

Metilfenidato e ADHD

Carucci, S. (2021) · Medico e Bambino · doi:10.53126/meb40325 · Cited by 1

ADHD in the Primary Care Setting

Hudak, R., & Gannon, J. M. (2022) · Current clinical practice · doi:10.1007/978-3-030-98709-1_8 · Cited by 1

Comparison of the Effectiveness of Pharmacotherapy and Neurofeedback on Improving Executive Functions in Children with Attention Deficit-Hyperactivity Disorder

Shalkouhi, F. H., Akbari, B., Bidabadi, E., & Moghtader, L. (2022) · Quarterly Journal of Child Mental Health · doi:10.52547/jcmh.9.1.13 · Cited by 1

The interplay of ADHD symptoms and exercise in youth

Ludyga, S., Weber, P., & Gallo, A. D. (2023) · Sports Psychiatry · doi:10.1024/2674-0052/a000047 · Cited by 1

Micronutrients in the Treatment of ADHD: Speculation or Opportunity?Preprint

Coppola, M., Mondola, R., & Bevione, F. (2022) · Preprints.org · doi:10.20944/preprints202212.0215.v1 · Cited by 1

Editorial: Attention-Deficit/Hyperactivity Disorder, Stimulant Medication, and Criminality: Commentary and Caution

Stein, M. A., Sibley, M. H., & Newcorn, J. H. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2023.08.003 · Cited by 1

La pagina gialla

Ventura, A. (2020) · Medico e Bambino · doi:10.53126/meb39417

Editors’ Best of 2020

Novins, D. K., Althoff, R. R., Cortese, S., Drury, S. S., Frazier, J. A., Henderson, S. W., McCauley, E., Njoroge, W., & White, T. J. H. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2020.11.005

Editorial: On the Safety of Long-term Methylphenidate Treatment of Attention-Deficit/Hyperactivity Disorder in Early Childhood

Vitiello, B. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2021.05.011

Impact of Parental Impulsivity on Attention Deficit Hyperactivity Disorder and Oppositional Defiant Disorder

Tulacı, Ö. D., Çetinkaya, M., Tulacı, R., Kara, H., Eraslan, A., & Durukan, İ. (2021) · Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001377

La pagina gialla

Ventura, A. (2020) · Medico e Bambino · doi:10.53126/meb39485

Longitudinal Associations Between Physical Activity, Body Mass Index and Inhibitory Control in Children with ADHD: Mediation by Brain StructurePreprint

Ludyga, S., & Ishihara, T. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4008157

9/m mit Konzentrationsstörungen

Geissler, J. M., Deserno, L., Romanos, M., Spiegler, J., & Jans, T. (2023) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-023-01702-0

Why not try a non-stimulant to treat ADHD?

Kripalani, M. (2023) · Annals of Pharmacology and Pharmaceutical Sciences · doi:10.52338/apps.2023.1023

Aufmerksamkeitsdefizit-/Hyperaktivitäts-Syndrom

Brotzmann, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65724-9_21

Fenómeno de Raynaud en un adolescente probablemente inducido por lisdexanfetamina

de la Peña, A. D., Martín-Gil, E., & Caminal‐Montero, L. (2023) · Revista de Psiquiatría Infanto-Juvenil · doi:10.31766/revpsij.v40n1a4

Estudo sobre tratamento de crianças pré-escolares com transtorno de déficit de atenção e hiperatividade e irritabilidade

Sugaya, L. S. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-20062023-124723

Manage early morning ADHD symptoms and functional impairment with treatments that are effective from awakening

Nie, T. (2023) · Drugs & Therapy Perspectives · doi:10.1007/s40267-023-01013-0

Neurodevelopmental Aspects of Behavioural Differences: I. Attention Deficit Hyperactivity Disorder (ADHD)

Stevenson, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-45787-6_9 · Cited by 1

Analisis Swot Dukungan Komunitas Masyarakat: Suatu Solusi Manajemen Kesehatan Jiwa Pada Remaja Di Indonesia

Pamungkasari, T., & Mulyanti, D. (2023) · Jurnal Ilmiah Kedokteran dan Kesehatan · doi:10.55606/klinik.v2i2.1324

Predicting Help-Seeking Behaviors in Caregivers of Children Newly Diagnosed with ADHD

Tamm, L., Girio-Herrera, E. L., Loren, R. E. A., Ciesielski, H. A., Narad, M. E., Zoromski, A. K., Epstein, J. N., Cook, T. E., Peugh, J., & Becker, S. P. (2023) · Evidence-Based Practice in Child and Adolescent Mental Health · doi:10.1080/23794925.2023.2284148

قصور الانتباه وعلاقته بمستوى الحصيلة اللغوية لدى الأطفال ذوي الإعاقة العقلية البسيطة

سالم, ب. م. أ. ب. (2023) · Maǧallaẗ Kulliyyaẗ Al-Tarbiyyaẗ Ǧāmiʻaẗ Al-Minufiyyaẗ /Maǧallaẗ Kulliyyaẗ Al-Tarbiyyaẗ Ǧāmiʻaẗ Al-Minufiyyaẗ · doi:10.21608/muja.2023.330112

The effectiveness of play therapy on the aggressive behavior of children with ADHD

Amiri, S. P., Nataj, K. A., & Fakhri, M. (2022) · doi:10.61838/kman.aftj.3.3.17

Application of Mobile Health Technology for Predicting attention-deficit/hyperactivity disorder (ADHD) for adolescent

Zearah, S. A., Alsalhy, M. J., Taha, A., Alatba, S. R., Fouad, L., & Jawad, I. A. (2023) · Annual International Conference on Emerging Research Areas and International Conference on Microelectronics, Communications and Renewable Energy · doi:10.1109/aicera/icis59538.2023.10420302

Transtorno do déficit de atenção/hiperatividade ao longo do desenvolvimento: epidemiologia, etiologia e terapêutica

Farhat, L. C. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-29022024-120617

Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I

Cortese, S., Besag, F., Clark, B., Hollis, C. P., Kilgariff, J., Moreno, C., Nicholls, D., Wilkinson, P. O., Woodbury‐Smith, M., & Sharma, A. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241239582 · Cited by 1

Ambulatory pediatricians: how to bridge the gaps in diagnosis and care coordination for neurodevelopmental disorders in France

Willig, T.-N., Blanc, J.-P., Assathiany, R., Bilbault, C., Raffier, L., & Werner, A. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1269198

Frequently asked questions about adverse drug reactions of methylphenidate

Heerfordt, I. M., & Horwitz, H. (2024) · Adverse Drug Reaction Bulletin · doi:10.1097/fad.0000000000000073

Why not try a non-stimulant to treat ADHD?

Kripalani, M. (2023) · Annals of Pharmacology and Pharmaceutical Sciences · doi:10.52338/apps.2023.1018

Therapeutic Use of Dopamine Enhancers (Stimulants)

Zuddas, A., & Carucci, S. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_138

Risques du méthylphénidate au long cours

Jurek, L., Cortese, S., & Nourredine, M. (2024) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2024.08.027

Psychopharmacology for Pediatric ADHD

Schumacher, L. T., & Greenhill, L. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-57472-6_8

Novel Drug Targets in Neuro-immune Disorders

Gorain, B., Karmakar, V., Pandey, M., Pooja, P., Sahoo, B. M., Senapati, D., & Bhattamisra, S. K. (2024) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-97-5508-0_9

Methylphenidate treatment of a Chinese boy with Becker muscular dystrophy combined with attention deficit hyperactivity disorder: a case report

Shen, F., & Zhou, H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1459582

Five Steps to Improve Cardiac Safety of Attention Deficit Hyperactivity Disorder Treatment

Dopheide, J. A., & Stutzman, D. L. (2024) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-29.6.670

Attention-Deficit/Hyperactivity Disorder

Solanto, M. V. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009086264.019

Does age of ADHD medication initiation predict long-term risk of anxiety? A scoping review

Fletcher, M., Ledbetter, L., Alonso, P., Ansah, O. O., Short, O., & Reuter‐Rice, K. (2025) · PLOS mental health. · doi:10.1371/journal.pmen.0000230

Comparison of Insomnia, Depression, and Perceived Social Support among Individuals with Amphetamine Use Disorder (AUD) and Healthy Controls

Abdoli, N., Bahmani, D. S., Salari, N., Khodamoradi, M., Stanga, Z. G., Brühl, A. B., Brand, S., & Dürsteler, K. M. (2025) · ALPHA PSYCHIATRY · doi:10.31083/ap38786

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report

Kim, J., Nichols, D. A., Zhang, T., Faraone, S. V., & Radonjić, N. V. (2025) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.70035

Treating Adolescent ADHD with Medication

Abbas, K., & Barnhardt, E. W. (2025) · Springer eBooks · doi:10.1007/978-3-031-96950-8_5

PHARMACOLOGICAL TREATMENT STRATEGIES FOR ADHD: A SYSTEMATIC REVIEW

Grzesikowski, P., Klich, P., Bekier, K., Kubiak, J., Górski, J., Nowicka, H., Liszka, D., Joks, M. M., Ordon, E., & Ostromecka, K. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3814 · Cited by 1

Addressing Treatment Disparities for Black Children with Neurodevelopmental Disorders

Clark, A. (2025) · American Journal of Qualitative Research · doi:10.29333/ajqr/17189

The Role of Pharmacotherapy in Social Cognition, Empathy, and Serum Oxytocin Levels in Children with Attention Deficit Hyperactivity Disorder: A Case–Control Study

Pekmez, H. O., Gamlı, İ. S., & Karakuş, O. B. (2025) · Children · doi:10.3390/children12101367 · Cited by 1

Effects of methylphenidate on growth, blood pressure, and heart rate in children and adolescents with ADHD

Hopkins, K., McCarthy, E. D., Babiker, M., Lane, C., Whelan, R., & McGrath, J. (2025) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2025.10097

Use of methylphenidate and the risk of cardiovascular diseases in children and adolescents with a family history of heart diseases and congenital heart diseases: A self-controlled case series study

Lee, M., Huang, C., Hung, T., Chen, Y., & Chen, V. C. (2025) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-025-02882-8

Brain plasticity underlying acquisition of new organizational skills in children: A Rashomon analysis

Agulleiro, L. M. M., Deng, B., Gallagher, R., Abikoff, H., Yoncheva, Y. N., Robinson, L., Conlon, G. R., Haroon, M., Yan, C., Martino, A. D., et al. (2025) · Frontiers in Neuroimaging · doi:10.3389/fnimg.2025.1671310

Abnormal Child Behavior in primary school students: A Bayesian network analysis

Till, A. C., Henry, T. R., Scutari, M., & Briganti, G. (2025) · L Encéphale · doi:10.1016/j.encep.2025.09.006

Additional file 1 of Goal management training for adults with ADHD – clients’ experiences with a group-based intervention

Nordby, E. S., Gilje, S., Jensen, D. A., Sørensen, L., & Stige, S. H. (2021) · Figshare · doi:10.6084/m9.figshare.14067984

Additional file 1 of Association of treatment procedures and resilience to symptom load three-years later in a clinical sample of adolescent psychiatric patients

Gårdvik, K. S., Rygg, M., Torgersen, T., Wallander, J. L., Lydersen, S., & Indredavik, M. S. (2021) · Figshare · doi:10.6084/m9.figshare.15569056

The role of gut microbiome modulation in the management of neurodevelopmental disorders: Current evidence and future directions

Protic, D. D., Nikolić, V., & Stojković, M. (2025) · Medicinski podmladak · doi:10.5937/mp76-60614

On/Off-Discrepancies in medical decision-making: utilising the reversibility of deep brain stimulation to strengthen patient autonomy

Meier, L. J., & D’Sa, A. (2026) · Ethik in der Medizin · doi:10.1007/s00481-025-00893-2

The intake of monosodium aspartate attenuates aggression induced by post-weaning social isolation in an ADHD rat model

Nishimura, Y., Mustika, D., Ueno, S., Tominaga, S., Shindo, M., Tajiri, N., Jung, C., & Hida, H. (2026) · The Journal of Physiological Sciences · doi:10.1016/j.jphyss.2026.100056

Impact of drug holidays on simulated driving performance in adults with ADHD: a study protocol for a randomized crossover trialPreprint

Li, N., Gambin, V., Quednow, B. B., Burger, P. H. M., Buadze, A., Offenhammer, B., Keller, K., & Lakämper, S. (2026) · Research Square · doi:10.21203/rs.3.rs-8611309/v1

Methylphenidate and Psychotic Symptoms in Children and Adolescents: A Disproportionality Analysis on the WHO Safety Database (VigiBase)

Chrétien, B., Blouet, C., Alexandre, J., Jardri, R., Nishida, K., Desaunay, P., & Guenolé, F. (2026) · Journal of Child and Adolescent Psychopharmacology · doi:10.1177/10445463261416450

Chronic Administration of Atomoxetine and Methylphenidate Induces Differential Alterations in the Hippocampus and Striatum of Young Rats

Bejarano-Coria, M., Beciez-Flores, D., & Corona, J. C. (2026) · Neurotoxicity Research · doi:10.1007/s12640-026-00782-6

Sex-Based Differences in Clinical and Social Outcomes in Qatari Youth with ADHD

Hashem, S., Elhag, S. F., Awada, Z., Aamer, W., Bhat, A. A., Al-Maraghi, A., Shaif, A., Aldhaibani, H., Fakhro, K. A., Nemer, G. M., et al. (2026) · Child Psychiatry & Human Development · doi:10.1007/s10578-026-01986-9

What Harm Can a Single Pill Do? Risks Associated With a Single Dose of Adderall

Kolla, B. P., & Mansukhani, M. P. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2026.01.023

The Pharmacotherapeutics of Methylphenidate and Atomoxetine for the Treatment of Childhood and Adolescent Attention Deficit-Hyperactivity Disorder

Sibbald, C., Sterling, W. J., Bennett, M., McNally, O., & Rogers, K. (2012) · Journal of Healthcare · doi:10.36959/569/451

Tratamiento actual del trastorno por déficit de atención e hiperactividad (TDAH) Actual treatment of attention defi cit hyperactivity disorder (ADHD)

Palomino, D., Guerrero, C. P., & Martín-Calero, J. (2013) · Cited by 1

The efficacy of methylphenidate and atomoxetine forvoiding dysfunction associated with attention deficit hyperactivity disorder

Tajima, D. (2017) · Japanese Society of Child Neurology

Pharmacological management of attention-deficit hyperactivity disorder

Reeves, G. M., & Schweitzer, J. B. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.6.1313 · Cited by 24

Current Pharmacological Treatments for ADHD

Groom, M. J., & Cortese, S. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_330 · Cited by 74